
|Articles|April 15, 2004
Cost of capital establishes a benchmark for evaluation of investments
"(The merchant's) capital is continually going from him in some shape, and returning to him in another."
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
2
Ocular Therapeutix randomizes first patient in HELIOS-3
3
AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care
4
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
5


















































.png)


